Skip to main content
Top
Published in: Cancer Causes & Control 12/2010

01-12-2010 | Original paper

From planning to implementation to outcomes: comprehensive cancer control implementation building blocks

Authors: Leslie S. Given, Karin Hohman, Lorrie Graaf, Phyllis Rochester, Lori Belle-Isle

Published in: Cancer Causes & Control | Issue 12/2010

Login to get access

Abstract

Since 2002, the US Centers for Disease Control and Prevention’s Guidance for Comprehensive Cancer Control Planning has been an important driver of success in the development of comprehensive cancer control (CCC) plans among states, tribes, tribal organizations, territories and Pacific Island Jurisdictions. CDC’s Guidance for Comprehensive Cancer Control Planning laid out a number of key action steps, or planning building blocks, that are essential to successful cancer plan development. Now, all 50 states and many tribes, tribal organizations, territories and Pacific Island Jurisdictions are actively implementing their comprehensive cancer control plans. This article describes a new set of key actions aimed at assisting CCC coalitions with systematic implementation of their cancer plan priorities—implementation building blocks for comprehensive cancer control.
Literature
Metadata
Title
From planning to implementation to outcomes: comprehensive cancer control implementation building blocks
Authors
Leslie S. Given
Karin Hohman
Lorrie Graaf
Phyllis Rochester
Lori Belle-Isle
Publication date
01-12-2010
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 12/2010
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9650-2

Other articles of this Issue 12/2010

Cancer Causes & Control 12/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine